Correction: Amplicon Indel Hunter Is a Novel Bioinformatics Tool to Detect Large Somatic Insertion/Deletion Mutations in Amplicon-Based Next-Generation Sequencing Data (Journal of Molecular Diagnostics (2015) 17(6) (635–643) (S1525157815001506) (10.1016/j.jmoldx.2015.06.005));Amplicon Indel Hunter Is a Novel Bioinformatics Tool to Detect Large Somatic Insertion/Deletion Mutations in Amplicon-Based Next-Generation Sequencing Data

Journal of Molecular Diagnostics

Volumn 17, Issue 6, 2015, Pages 635-643

  Kadri, Sabah ^a   Zhen, Chao J ^a   Wurst, Michelle N ^a   Long, Bradley C ^a   Jiang, Zi Feng ^a   Wang, Y Lynn ^a   Furtado, Larissa V ^a   Segal, Jeremy P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN;

AGAR GEL ELECTROPHORESIS; ALGORITHM; AMPLICON; AMPLICON INDEL HUNTER; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CLINICAL ASSESSMENT TOOL; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE INSERTION SEQUENCE; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; NEXT GENERATION SEQUENCING; SOMATIC MUTATION; BIOLOGY; COMPUTER PROGRAM; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; COMPUTATIONAL BIOLOGY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDEL MUTATION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SOFTWARE;

EID: 84943598745     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2017.03.002     Document Type: Erratum

References (14)

1. C. Meldrum, M.A. Doyle, and R.W. Tothill Next-generation sequencing for cancer diagnostics: a practical perspective Clin Biochem Rev 32 2011 177 195
2. R. Luthra, K.P. Patel, N.G. Reddy, V. Haghshenas, M.J. Routbort, M.A. Harmon, B.A. Barkoh, R. Kanagal-Shamanna, F. Ravandi, J.E. Cortes, H.M. Kantarjian, L.J. Medeiros, and R.R. Singh Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring Haematologica 99 2014 465 473
3. B.B. Simen, L. Yin, C.P. Goswami, K.O. Davis, R. Bajaj, J.Z. Gong, S.C. Peiper, E.S. Johnson, and Z.X. Wang Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory Arch Pathol Lab Med 139 2015 508 517
4. E.J. Duncavage, H.J. Abel, P. Szankasi, T.W. Kelley, and J.D. Pfeifer Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia Mod Pathol 25 2012 795 804
5. K. Chen, J.W. Wallis, M.D. McLellan, D.E. Larson, J.M. Kalicki, C.S. Pohl, S.D. McGrath, M.C. Wendl, Q. Zhang, D.P. Locke, X. Shi, R.S. Fulton, T.J. Ley, R.K. Wilson, L. Ding, and E.R. Mardis BreakDancer: an algorithm for high-resolution mapping of genomic structural variation Nat Methods 6 2009 677 681
6. K. Ye, M.H. Schulz, Q. Long, R. Apweiler, and Z. Ning Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads Bioinformatics 25 2009 2865 2871
7. R. Daber, S. Sukhadia, and J.J. Morrissette Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets Cancer Genet 206 2013 441 448
8. Li H: Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at arXiv:1303.3997v2 [q-bio.GN].
9. J.T. Robinson, H. Thorvaldsdóttir, W. Winckler, M. Guttman, E.S. Lander, G. Getz, and J.P. Mesirov Integrative genomics viewer Nat Biotechnol 29 2011 24 26
10. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, and R. Durbin 1000 Genome Project Data Processing Subgroup: The Sequence Alignment/Map format and SAMtools Bioinformatics 25 2009 2078 2079
11. M. Nakao, S. Yokota, T. Iwai, H. Kaneko, S. Horiike, K. Kashima, Y. Sonoda, T. Fujimoto, and S. Misawa Internal tandem duplication of the flt3 gene found in acute myeloid leukemia Leukemia 10 1996 1911 1918
12. P.D. Kottaridis, R.E. Gale, M.E. Frew, G. Harrison, S.E. Langabeer, A.A. Belton, H. Walker, K. Wheatley, D.T. Bowen, A.K. Burnett, A.H. Goldstone, and D.C. Linch The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Blood 98 2001 1752 1759
13. C.C. Smith, Q. Wang, C.S. Chin, S. Salerno, L.E. Damon, M.J. Levis, A.E. Perl, K.J. Travers, S. Wang, J.P. Hunt, P.P. Zarrinkar, E.E. Schadt, A. Kasarskis, J. Kuriyan, and N.P. Shah Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia Nature 485 2012 260 263
14. F.M. Abu-Duhier, A.C. Goodeve, G.A. Wilson, R.S. Care, I.R. Peake, and J.T. Reilly Genomic structure of human FLT3: implications for mutational analysis Br J Haematol 113 2001 1076 1077